GlycoMimetics
GLYC
#10915
Rank
โ‚ฌ9.22 M
Marketcap
0,14ย โ‚ฌ
Share price
-5.42%
Change (1 day)
-38.63%
Change (1 year)

Revenue for GlycoMimetics (GLYC)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚ฌ0 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlycoMimetics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 โ‚ฌ0 M-87.06%
2022 โ‚ฌ0.06 M-93.17%
2021 โ‚ฌ1.02 M-87.61%
2020 โ‚ฌ8.26 M
2019 N/A
2018 N/A
2017 N/A-100%
2016 โ‚ฌ0.01 M-99.9%
2015 โ‚ฌ18.35 M48.57%
2014 โ‚ฌ12.35 M327.37%
2013 โ‚ฌ2.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ90.45 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ57.93 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ53.40 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
Palatin Technologies
PTN
โ‚ฌ12 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ94.65 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA